Keywords: evt101, completes, ph, ad, study, says, evotec

EVT101 completes Ph I AD study, says Evotec

Article | 14 August 2006

Print This

German drug discovery firm Evotec AG says that it has successfully completed a Phase I trial of EVT 101, its developmental ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in